"cancer resistance" trang 11 - tải miễn phí từ tailieuXANH
Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: A case report

Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: A case report
6    64    0
MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma

MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
13    61    0
Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells

Aggregation of lipid rafts activates c-met and c-Src in non-small cell lung cancer cells
11    80    0
Potential mechanisms of resistance to venetoclax and strategies to circumvent it

Potential mechanisms of resistance to venetoclax and strategies to circumvent it
10    114    0
A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer

A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer
13    48    0
HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner

HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner
8    69    0
Generation and characterization of MEK and ERK inhibitors- resistant non-smallcells-lung-cancer (NSCLC) cells

Generation and characterization of MEK and ERK inhibitors- resistant non-smallcells-lung-cancer (NSCLC) cells
7    57    0
Case report: Primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation

Case report: Primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation
4    73    0
Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasion

Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasion
12    58    0
Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration

Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration
11    107    0
Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormonesensitive breast cancer

Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormonesensitive breast cancer
11    35    0
Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APCmin mouse model of spontaneous familial adenomatous polyposis

Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APCmin mouse model of spontaneous familial adenomatous polyposis
10    44    0
Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by Nacetylcysteine

Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by Nacetylcysteine
16    45    0
MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib

MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib
12    59    0
IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis

IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis
16    57    0
S6Ks isoforms contribute to viability, migration, docetaxel resistance and tumor formation of prostate cancer cells

S6Ks isoforms contribute to viability, migration, docetaxel resistance and tumor formation of prostate cancer cells
9    42    0
Identification of epigenetic factors regulating the mesenchyme to epithelium transition by RNA interference screening in breast cancer cells

Identification of epigenetic factors regulating the mesenchyme to epithelium transition by RNA interference screening in breast cancer cells
11    51    0
P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangement

P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangement
11    58    0
Overexpression of 17β-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death

Overexpression of 17β-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death
15    50    0
Factors influencing participation in a randomized controlled resistance exercise intervention study in breast cancer patients during radiotherapy

Factors influencing participation in a randomized controlled resistance exercise intervention study in breast cancer patients during radiotherapy
9    56    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.